EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut hormone stimulation as a therapeutic approach in oral peptide delivery

Ana Beloqui

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.07.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Ana Beloqui. Beteiligte Einrichtung: UCLouvain, Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, 1200 Brussels, Belgium; WEL Re…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Gastrointestinal Hormones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this contribution to the Orations - New Horizons of the Journal of Controlled Release, I discuss the research that we have conducted on gut hormone stimulation as a therapeutic strategy in oral peptide delivery. One of the greatest challenges in oral drug delivery involves the development of new drug delivery systems that enable the absorption of therapeutic peptides into the systemic circulation at therapeutically relevant concentrations. This scenario is especially challenging in the treatment of chronic diseases (such as type 2 diabetes mellitus), wherein daily injections are often needed. However, for certain peptides, there may be an alternative in drug delivery to meet the need for increased peptide bioavailability; this is the case for gut hormone mimetics (including glucagon-like peptide (GLP)-1 or GLP-2). One plausible alternative for improved oral delivery of these peptides is the co-stimulation of the endogenous secretion of the hormone to reach therapeutic levels of the peptide. This oration will be focused on studies conducted on the stimulation of gut hormones secreted from enteroendocrine L cells in the treatment of gastrointestinal disorders, including a critical discussion of the limitations and future perspectives of implementing this approach in the clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsGastrointestinal HormonesAnimalsHumansAdministration, OralEnteroendocrine CellsGlucagon-Like Peptide 1Glucagon-Like Peptide 2Biological Availability

Stichwörter der Autor:innen

GLP-1GLP-2Gut hormoneHormone stimulationL cellsOral peptide delivery

Substanzen

Gastrointestinal HormonesGlucagon-Like Peptide 1Glucagon-Like Peptide 2

Autor:innen und Institutionen

  • UCLouvain, Université catholique de Louvain, Louvain Drug Research Institute, Advanced Drug Delivery and Biomaterials, 1200 Brussels, Belgium; WEL Research Institute, Avenue Pasteur, 6, 1300 Wavre, Belgium. Electronic a…

Zitieren

APA

Beloqui, A. (2024). Gut hormone stimulation as a therapeutic approach in oral peptide delivery. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.07.007

Vancouver

Beloqui A. Gut hormone stimulation as a therapeutic approach in oral peptide delivery. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.07.007

BibTeX
@article{Beloqui2024,
  author = {Beloqui, Ana},
  title = {Gut hormone stimulation as a therapeutic approach in oral peptide delivery},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.07.007}
}
Kostenlos starten →